Kinase inhibitor
US9499486B2 · kind B2 · utility
11Cited by
24References
10Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Oct 1, 2015 |
| Grant date | Nov 22, 2016 |
| Priority date | — |
| Expiry date | Oct 1, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a compound of formula I,which compound has anti-inflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and has use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.